Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder

Phase 2

Completed

Conditions: Schizoaffective Disorder
Schizophrenia
Depression
Substance Abuse
HIV Infections
Bipolar Disorder

Interventions: Behavioral: Enhanced treatment as usual
Drug: Twinrix

First Posted Date: 2006-04-20

Last Posted Date: 2013-05-22

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 236

Registration Number: NCT00316303

Locations: 🇺🇸
University of Maryland, Department of Psychaitry, Baltimore, Maryland, United States

Aspirin/Folate Prevention of Large Bowel Polyps

Phase 2

Completed

Conditions: Adenomas
Colorectal Cancer
Polyps

First Posted Date: 2006-01-05

Last Posted Date: 2020-03-13

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 1121

Registration Number: NCT00272324

Locations: 🇺🇸
USC/Kaiser, Los Angeles, California, United States
🇺🇸
University of Colorado, Denver, Colorado, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States

and more 6 locations

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: counseling intervention
Other: educational intervention
Procedure: psychosocial assessment and care
Procedure: quality-of-life assessment

First Posted Date: 2005-11-15

Last Posted Date: 2014-12-19

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 329

Registration Number: NCT00253383

Locations: 🇺🇸
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸
Veterans Affairs Medical Center - White River Junction, White River Junction, Vermont, United States

Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Cetuximab/Gemcitabine
Procedure: Radiotherapy

First Posted Date: 2005-09-26

Last Posted Date: 2014-07-16

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 37

Registration Number: NCT00225784

Ghrelin Levels in Pancreatic Cancer Patients

Completed

Conditions: Pancreatic Cancer

Interventions: Procedure: Blood draw

First Posted Date: 2005-09-26

Last Posted Date: 2015-10-14

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 72

Registration Number: NCT00225745

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Medication Adherence in Older Adults With Serious Mental Illness

Not Applicable

Completed

Conditions: Schizophrenia
Bipolar Disorder
Depression

First Posted Date: 2005-09-23

Last Posted Date: 2009-09-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 72

Registration Number: NCT00224380

Locations: 🇺🇸
Community Council of Nashua, Nashua, New Hampshire, United States

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

Phase 2

Completed

Conditions: Nonresectable Adrenocortical Carcinoma

First Posted Date: 2005-09-22

Last Posted Date: 2018-05-17

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 16

Registration Number: NCT00215202

Locations: 🇺🇸
Kentuckiana Cancer Institute PLLC, Louisville, Kentucky, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

and more 1 locations

Evaluation of a Health Promotion Intervention for Persons With Mental Illness

Completed

Conditions: Mental Illness

First Posted Date: 2005-09-22

Last Posted Date: 2009-09-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 145

Registration Number: NCT00215189

Locations: 🇺🇸
Monadnock Family Services, Keene, New Hampshire, United States

The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women

Phase 3

Completed

Conditions: Post-Traumatic Stress Disorder
Mental Disorders
Depression

Interventions: Behavioral: Trauma Recovery and Empowerment Model (TREM)
Behavioral: Usual care

First Posted Date: 2005-09-16

Last Posted Date: 2012-07-23

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 300

Registration Number: NCT00183716

Locations: 🇺🇸
Community Connections, Washington, District of Columbia, United States
🇺🇸
The North Baltimore Center, Baltimore, Maryland, United States

Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function

Phase 2

Terminated

Conditions: Metastatic Breast Cancer

Interventions: Drug: G-CSF
Drug: trastuzumab
Drug: vinorelbine
Drug: saline placebo

First Posted Date: 2005-09-15

Last Posted Date: 2018-07-20

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 23

Registration Number: NCT00169104

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy